South Korea · Delayed Price · Currency is KRW Daewoong Pharmaceutical Statistics
Total Valuation
KRX:069620 has a market cap or net worth of KRW 2.02 trillion. The enterprise value is 2.76 trillion.
| Market Cap | 2.02T |
| Enterprise Value | 2.76T |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:069620 has 11.51 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 23.82% |
| Float | 5.37M |
Valuation Ratios
The trailing PE ratio is 21.65 and the forward PE ratio is 12.17. KRX:069620's PEG ratio is 0.20.
| PE Ratio | 21.65 |
| Forward PE | 12.17 |
| PS Ratio | 1.31 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 15.35 |
| PEG Ratio | 0.20 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.51, with an EV/FCF ratio of -145.19.
| EV / Earnings | 29.63 |
| EV / Sales | 1.79 |
| EV / EBITDA | 13.51 |
| EV / EBIT | 17.94 |
| EV / FCF | -145.19 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.22 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | -41.71 |
| Interest Coverage | 16.73 |
Financial Efficiency
Return on equity (ROE) is 9.61% and return on invested capital (ROIC) is 6.96%.
| Return on Equity (ROE) | 9.61% |
| Return on Assets (ROA) | 5.66% |
| Return on Invested Capital (ROIC) | 6.96% |
| Return on Capital Employed (ROCE) | 11.75% |
| Revenue Per Employee | 937.74M |
| Profits Per Employee | 56.68M |
| Employee Count | 1,644 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, KRX:069620 has paid 17.38 billion in taxes.
| Income Tax | 17.38B |
| Effective Tax Rate | 15.37% |
Stock Price Statistics
The stock price has increased by +37.37% in the last 52 weeks. The beta is 0.46, so KRX:069620's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +37.37% |
| 50-Day Moving Average | 145,790.00 |
| 200-Day Moving Average | 141,301.00 |
| Relative Strength Index (RSI) | 68.46 |
| Average Volume (20 Days) | 70,953 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:069620 had revenue of KRW 1.54 trillion and earned 93.19 billion in profits. Earnings per share was 8,098.35.
| Revenue | 1.54T |
| Gross Profit | 800.86B |
| Operating Income | 189.43B |
| Pretax Income | 113.07B |
| Net Income | 93.19B |
| EBITDA | 239.83B |
| EBIT | 189.43B |
| Earnings Per Share (EPS) | 8,098.35 |
Balance Sheet
The company has 208.62 billion in cash and 793.01 billion in debt, giving a net cash position of -584.39 billion or -50,788.79 per share.
| Cash & Cash Equivalents | 208.62B |
| Total Debt | 793.01B |
| Net Cash | -584.39B |
| Net Cash Per Share | -50,788.79 |
| Equity (Book Value) | 1.04T |
| Book Value Per Share | 76,475.31 |
| Working Capital | 140.68B |
Cash Flow
In the last 12 months, operating cash flow was 131.44 billion and capital expenditures -150.46 billion, giving a free cash flow of -19.01 billion.
| Operating Cash Flow | 131.44B |
| Capital Expenditures | -150.46B |
| Free Cash Flow | -19.01B |
| FCF Per Share | -1,652.54 |
Margins
Gross margin is 51.95%, with operating and profit margins of 12.29% and 6.04%.
| Gross Margin | 51.95% |
| Operating Margin | 12.29% |
| Pretax Margin | 7.33% |
| Profit Margin | 6.04% |
| EBITDA Margin | 15.56% |
| EBIT Margin | 12.29% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 600.00, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 600.00 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.66% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.35% |
| Earnings Yield | 4.62% |
| FCF Yield | -0.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2012. It was a forward split with a ratio of 1.03.
| Last Split Date | Dec 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:069620 has an Altman Z-Score of 2.27 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.27 |
| Piotroski F-Score | 6 |